Ranitidine HCL Injection

Active Ingredients: Ranitidine HCL

Ranitidine HCL Injection is used to treat duodenal, benign gastric, and post-operative ulcers. This drug is used to treat conditions associated with excess stomach acid, such as Zollinger-Ellison Syndrome. It may also be used to prevent Mendelson's Syndrome (acid aspiration) before anesthesia in at-risk patients

This medication is indicated as prophylaxis for gastrointestinal bleeding caused by ulcers in patients with serious illness and recurrent hemorrhage associated with bleeding peptic ulcers. Ranitidine HCL Injections are approved for children over 6 months old for the treatment of gastroesophageal reflux disorder and the short-term treatment of peptic ulcers.

Ranitidine HCL is in a class of medications called H2 blockers. The active ingredient works by blocking histamine from the H2 receptors. This decreases the amount of acid produced in the stomach.

Ranitidine HCL injection is available in 2ml ampoules that contain 50mg Ranitidine in a 2ml aqueous solution. Each 1ml contains 25mg of Ranitidine.

AdvaCare Pharma is a global distributor and manufacturer of Ranitidine HCL Injections. Our supply chain is thoroughly vetted to ensure it meets health, safety, and environmental standards. This medication is produced in our GMP-certified facilities in China, India, and the USA.

AdvaCare Pharma is an American-owned pharmaceutical company that specializes in the manufacture of Ranitidine HCL Injection and other quality-assured injectable medications for the worldwide market. Over the past twenty years, we’ve built our reputation on reliable, efficacious, and affordable medical products and custom-tailored marketing plans to meet regional demands.

What is Ranitidine HCL used for?

It's used to treat duodenal, benign gastric, and post-operative ulcers. It's used to treat certain conditions associated with excess stomach acid such as Zollinger-Ellison Syndrome or reflux esophagitis.

It may also be used to prevent Mendelson's Syndrome (acid aspiration) before anesthesia in at-risk patients, gastrointestinal bleeding caused by ulcers in patients with serious illnesses, and recurrent hemorrhage associated with bleeding peptic ulcers.

How is Ranitidine HCL Injection used?

This medication has been manufactured as a solution. It should be administered by IV/IM injection or intravenously with a calibrated infusion device at a slow and controlled rate.

What dose should be given?

The usual dose for adults and children is dependent on the patient and the medical condition.

It is recommended not to exceed 10mEQ/hour or 200mEQ/day if the patient's potassium level is greater than 2.5mEQ/liter.

When administering a Ranitidine HCL Injection, it is especially important to monitor cardiac function, potassium concentration, and acid-base balance. It should not be infused rapidly in order to avoid potassium intoxication.

As with all pharmaceuticals, some unwanted effects can occur from the use of Ranitidine HCL Injection.

Serious side effects may include: • signs of an allergic reaction

For a comprehensive list of all side effects, consult a doctor or pharmacist.

If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor.

Due to possible drug interactions, consult with your doctor about any medications you are taking before your treatment.

This medication may not be suitable for people with certain conditions, so it is important to consult with a doctor if you have any health conditions.